FDA Orange Book · active-ingredient family
Estrogens, conjugated synthetic a
Estrogens, conjugated synthetic a is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:CENESTIN · NDA 020992
2
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · cream, tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| CENESTINRLD×5 | ASPEN | NDA 020992 | — | Jun 21, 2002 | |
| SYNTHETIC CONJUGATED ESTROGENS A | TEVA WOMENS | NDA 021788 | — | Nov 28, 2008 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Estrogens, conjugated synthetic a — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

